Evidence map›Paper›PMID 35615473›Full record

ReviewFrontiers in bioengineering and biotechnology2022

Recent Progress on Feasible Strategies for Arbutin Production.

Ke-Xin Xu, Meng-Ge Xue, Zhimin Li, Bang-Ce Ye, Bin Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Disrupting melanin transfer: innovative strategy for anti-pigmentation drug discovery.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Selection of aLife (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Hirsutanone Isolated from the Bark ofPlants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ke-Xin XuJiangxi Engineering Laboratory for the Development and Utilization of Agricultural Microbial Resource, College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, China.
Meng-Ge XueJiangxi Engineering Laboratory for the Development and Utilization of Agricultural Microbial Resource, College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, China.
Zhimin LiJiangxi Engineering Laboratory for the Development and Utilization of Agricultural Microbial Resource, College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, China.
Bang-Ce YeCollege of Bioengineering, East China University of Science and Technology, Shanghai, China.
Bin ZhangJiangxi Engineering Laboratory for the Development and Utilization of Agricultural Microbial Resource, College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang, China.
Jiangxi Agricultural University · CNEast China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arbutin is a hydroquinone glucoside and a natural product present in various plants. Arbutin potently inhibits melanin formation. This property has been exploited in whitening cosmetics and pharmaceuticals. Arbutin production relies mainly on chemical synthesis. The multi-step and complicated process can compromise product purity. With the increasing awareness of sustainable development, the current research direction prioritizes environment-friendly, biobased arbutin production. In this review, current strategies for arbutin production are critically reviewed, with a focus on plant extraction, chemical synthesis, biotransformation, and microbial fermentation. Furthermore, the bottlenecks and perspectives for future direction on arbutin biosynthesis are discussed.

Indexed as

arbutinbiotransformationchemical synthesismicrobial fermentationplant extraction

Identifiers

PMID35615473
PMCPMC9125391
OpenAlexW4229378067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.